BrightSpring Health Services 2Q 2026: Revenue $3.87B, EPS $0.39— 10-Q SummaryTradingView·1 day ago, 07:51 AMBTSG-18.07%
MOG.A: Record sales, margin expansion, and raised guidance highlight robust performance and outlookQuartr·1 day ago, 07:45 AMMOG.A-7.01%
BrightSpring Q2 Income Rises, Raises FY26 Guidance, Shares Downrttnews·1 day ago, 07:03 AMBTSG-18.07%
Moog Q3 FY26 diluted EPS more than doubled to $4.74; net sales rise 15% to $1.12 billionPUBT·1 day ago, 06:55 AMMOG.A-7.01%MOG.B0.00%
Moog Inc. Achieves Record Third Quarter 2026 Results Through Operational Excellence and Raises Full-Year GuidanceUnusual Whales·1 day ago, 06:58 AMMOG.A-7.01%MOG.B0.00%
BrightSpring Q2 2026 earnings: Pharmacy economics lift profit and guidanceTradingKey·1 day ago, 05:22 AMBTSG-18.07%
Moog | 8-K: FY2026 Q3 Revenue Beats Estimate at USD 1.117 BEarnings Watch·1 day ago, 07:47 AMMOG.A-7.01%
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | BTSG Stock NewsStockTitan·1 day ago, 09:00 PMBTSG-18.07%
GKOS: Q2 sales surged 50% year-over-year, led by iDose TR and Epioxa, with guidance raised to $680M–$700MQuartr·Jul 29 at 05:57 PMGKOS-1.07%
Glaukos (NYSE:GKOS) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPSMarket Beat·Jul 29 at 07:26 PMGKOS-1.07%
Moog shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS and sales guidance above estimates.benzinga_article·1 day ago, 09:32 AMMOG.A-7.01%MOG.B0.00%
U.S. stock market update: BrightSpring down 15.31%, raised expectations fail to mask cash flow concernsPrice Alert·1 day ago, 09:33 AMBTSG-18.07%
Glaukos Corp.’s Anti-Takeover Defenses Raise Governance Risk and Potentially Depress Shareholder ValueTip Ranks·1 day ago, 01:00 AMGKOS-1.07%
